Search Results

The ONLINE TDM Valproic Acid assay is for the quantitative determination of valproic acid in human serum or plasma on Roche automated clinical chemistry analyzers. Measurements muman serain of paintine were used in the diagnosis and treatement of valproic acid overdose and in monitoring the levels of valproic acid to help ensure appropriate therapy.

The ONLINE TDM Valproic Acid assay is for the quantitative determination of valproic acid in human serum or plasma on Roche automated clinical chemistry analyzers. The proposed labeling indicates the Roche Hitachi 911, 912, 917 and Modular P analyzers can be used with the Roche ONLINE TDM Valproic Acid reagent kits. The assay is based on a homogeneous enzyme immunoassay technique used for the quantitative analysis of valproic acid (free and protein-bound) in human serum or plasma. The assay is based on competition between drug in the sample and drug labeled with the enzyme glucose-6-phosphate dehydrogenase (G6PDH) for antibody binding sites. Enzyme activity decreases upon binding to the antibody, so the drug concentration in the sample can be measured in terms of enzyme activity. Active enzyme converts oxidized nicotinamide adenine dinucleotide (NAD) to NADH, resulting in an absorbance change that is measured spectrophotometrically. Endogenous serum G6PDH does not interfere because the coenzyme functions only with the bacterial (Leuconostoc mesenteroids) enzyme employed in the assay.

This submission describes the Roche ONLINE TDM Valproic Acid assay, an in-vitro diagnostic device. As such, the concept of "acceptance criteria" and "study" in the context of imaging devices or algorithms with human interpretation is not directly applicable in the same way.

Instead, for this device, the "acceptance criteria" are based on demonstrating substantial equivalence to a predicate device (Roche COBAS INTEGRA Valproic Acid, K951595) through performance characteristics typically evaluated for quantitative assays.

Here's an analysis based on the provided text, reinterpreting the questions for this type of device:

1. Table of Acceptance Criteria and Reported Device Performance

For this in-vitro diagnostic, "acceptance criteria" are implied by acceptable ranges for analytical performance characteristics that demonstrate substantial equivalence to the predicate. The study aimed to show that the new device's performance aligns with or is comparable to the predicate.

Note: The document doesn't explicitly state numerical acceptance criteria, but rather implies that the results should be "acceptable" and comparable to the predicate device to establish substantial equivalence. For precision, the values are compared directly. For method comparison, linearity, high correlation, and a near-zero intercept with a slope near one are generally expected.

2. Sample Size Used for the Test Set and the Data Provenance

• Precision Studies:
  • The sample size per control level for precision studies is not explicitly stated in the summary table. It only shows "Mean", "SD", and "CV%", which are derived from multiple measurements.
  • Data provenance is not specified (e.g., country of origin, retrospective/prospective).
• Method Comparison Study:
  • N=54 samples were used for the comparison between ONLINE TDM Valproic Acid and COBAS FP Valproic acid.
  • N=207 samples were used for the predicate comparison against COBAS FARA II (this is the predicate device's historical comparison, not the new device's).
  • Data provenance is not specified (e.g., country of origin, retrospective/prospective). The samples are human serum or plasma.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts

This type of information is not applicable for this device. For an in-vitro diagnostic assay that measures a chemical concentration, the "ground truth" is typically established by reference methods or highly accurate analytical techniques, not by expert consensus or interpretation of images. The comparison is made against the predicate device, which itself has an established accuracy.

4. Adjudication Method for the Test Set

This is not applicable for this type of in-vitro diagnostic device. Adjudication typically refers to resolving discrepancies between multiple human readers or between human readers and an AI, which is not relevant here.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If so, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance

This is not applicable for this device. This assay is a standalone chemical measurement device, not an imaging device or an AI designed to assist human readers.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

Yes, the studies presented are effectively standalone performance studies of the device (the "algorithm" being the assay's chemical reaction and detection system). The reported precision and method comparison data reflect the performance of the device itself, without human interpretation as part of the measurement outcome.

7. The Type of Ground Truth Used

The "ground truth" in this context is the measurement obtained from the predicate device (COBAS FP Valproic acid) or, indirectly, from a well-established reference method or a previously validated assay against which the predicate itself was compared (e.g., COBAS FARA II in the predicate's comparison). The goal is to show agreement with an already accepted method for quantifying valproic acid.

8. The Sample Size for the Training Set

This is not applicable as this is not a machine learning or AI-based device that requires a training set in the conventional sense. The "training" of the assay involves optimizing its chemical reagents and reaction conditions, which is part of the assay development process, not a data-driven training set for an algorithm.

9. How the Ground Truth for the Training Set Was Established

This is not applicable as there is no "training set" for an algorithm in this context.

Ask a specific question about this device